Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Hartford, Connecticut 06040


Purpose:

Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The child's pain with the access procedure is evaluated.


Criteria:

Inclusion Criteria: - Children ages 3-17 with subcutaneous port Exclusion Criteria: - Emergent need for port access - Allergy to lidocaine sodium lauryl sulfate


NCT ID:

NCT00126919


Primary Contact:

Principal Investigator
William T. Zempsky, MD
CT Children's Medical Center


Backup Contact:

N/A


Location Contact:

Hartford, Connecticut 06040
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 10, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.